Investors
A patented technology as the basis for many brands.
Investment Thesis
Our investment story is based on three pillars of market strength. We combine patented research with the highest market acceptance and scalability. A clear unique selling proposition through DermaMimetic® secures long-term competitive advantages in the growing
clean beauty market.
Patent protection
The DermaMimetic technology is comprehensively protected by patents. This secures us exclusive usage rights in key European markets.
Patented technology as a sustainable competitive advantage
Unique selling proposition
Our lamellar membrane technology offers a significant advantage over conventional emulsifier-based systems.
Technology & Innovation
Advantage
The combination of technological know-how and legal protection creates an impregnable market barrier for imitators.
Business Model
01
Private Label
Scalable revenue engine through contract manufacturing for partner brands based on our patented technology.
02
Signature Line
Unsere Premium-Referenzlinie als Technologieträger und Markenschaufenster für höchste Performance-Ansprüche.
03
Licensing
Efficient reach leverage through the licensing of our DermaMimetic® quality seal for selected formulations.
Traction & KPIs
Proven growth and scalability.
Partner brands
Successfully implemented private label collaborations.
Production volume
Scalable manufacturing capacities according to the highest ISO standards.
Growth
Continuous increase in market share in EU contract manufacturing, the USA, and Asia.
Market & Potential
Contract manufacturing for premium cosmetics: A growth market with high barriers to entry due to patented innovations.
$ 192.3 billion
EU Market Volume
Based on current market analyses for global contract manufacturing of premium cosmetics.
Source: Statista, Global Wellness Institute, Research Nester
7.1%
Annual growth
25%
Niche market share
Leadership
Behind the vision.
Joachim Biesold
Founder & Managing Director
With decades of expertise in biomimetic skin research, Joachim Biesold is the mind behind the DermaMimetic® technology. His vision is to harmonize science and naturalness to make highly effective skincare accessible to the global market.
His focus is on the strategic development of technology partnerships and the continuous innovation of our pipeline.
Direct contact with management
Do you have questions about our investment story or our technology? Mr. Joachim Biesold is happy to be at your disposal for a personal exchange.
This presentation does not constitute a public offer or an investment recommendation.